Details for Patent: 10,028,920
✉ Email this page to a colleague
Which drugs does patent 10,028,920 protect, and when does it expire?
Patent 10,028,920 protects TRYPTYR and is included in one NDA.
This patent has ten patent family members in four countries.
Drugs Protected by US Patent 10,028,920
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon Labs Inc | TRYPTYR | acoltremon | SOLUTION/DROPS;OPHTHALMIC | 217370-001 | May 28, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | TREATMENT OF THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE (DED) | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,028,920
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2614860 | ⤷ Start Trial | |||
| European Patent Office | 4268814 | ⤷ Start Trial | |||
| Spain | 2377785 | ⤷ Start Trial | |||
| Japan | 2013537887 | ⤷ Start Trial | |||
| Japan | 2017036298 | ⤷ Start Trial | |||
| Japan | 2019131621 | ⤷ Start Trial | |||
| Japan | 2021107422 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
